NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

The National Institutes of Health (NIH) is offering a grant opportunity titled "NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices," aimed at advancing the development and translation of innovative technologies for preventing, monitoring, diagnosing, and treating disorders related to the NIH's BRAIN and HEAL initiatives. This funding opportunity encourages applications from a diverse range of eligible applicants, including Indian/Native American Tribal Governments, federal agencies, and foreign institutions, to facilitate the translation of new devices to the stage of readiness for first-in-human clinical trials by addressing challenges identified in preliminary studies. The total estimated funding for this program is $6 million, with an expected four awards to be made, and interested parties can reach out to NIBIB Program Officers via email at NIBIB_Devices@NIH.gov for further information. Key deadlines include an estimated synopsis close date of September 18, 2026, and an anticipated project start date of July 18, 2027.